BioSpace News Archive

Policy

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years

Pfizer Inc. and BioNTech SE announced the U.S. Food and Drug Administration granted Emergency Use Authorization of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third 3-µg dose in the three-dose primary series for children 6 months through 4 years of age.

December 8, 2022
·
21 min read
Dialysis Market Size To Hold around USD 196.1 Billion By 2030

The global dialysis market size was exhibited at USD 116.07 billion in 2022 and is expected to hold around USD 196.1 billion by 2030, growing at a CAGR of 6.78% from 2022 to 2030.

December 8, 2022
·
8 min read
Pharm Country

$11M NIH Grant Will Support Evaluation of Alzheimer’s Screening Tool in Primary Care Settings

Investigators at Albert Einstein College of Medicine, Montefiore Health System, Regenstrief Institute, and Indiana University School of Medicine have received an $11 million grant from the National Institutes of Health to evaluate an Einstein-developed test for assessing cognitive impairment and dementia.

December 8, 2022
·
6 min read
Drug Development

Sermonix Pharmaceuticals Announces Poster Presentation on Phase 1 Ethnobridging Study of Lasofoxifene at the 12th AACR-JCA Joint Conference: Breakthroughs in Cancer Research — Translating Knowledge Into Practice

Sermonix Pharmaceuticals Inc. announced that it will share a poster presentation at the 12th AACR-JCA Joint Conference: Breakthroughs in Cancer Research — Translating Knowledge into Practice, which is being held December 10-14 in Maui, Hawaii.

December 8, 2022
·
4 min read
Pharm Country

Medidata Receives Prestigious Innovation Award from Reagan-Udall Foundation for the FDA

Medidata, a Dassault Systèmes company, has been honored by the Reagan-Udall Foundation for the Food and Drug Administration (FDA) with its 2022 Innovation in Regulatory Science Award for Medidata Link.

December 8, 2022
·
4 min read
Annual Scientific Sessions for the Prevention of Cardiovascular Disease Coming to the Dallas-Fort Worth Metroplex July 2023

The American Society for Preventive Cardiology announces a full program of events to be held at their annual Congress on Cardiovascular Disease Prevention, scheduled in 2023 for July 19-23 hosted at the Live! By Loews hotel in Arlington, TX.

December 8, 2022
·
3 min read
Biotech Beach

EDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL INVESTOR CONFERENCE - December 8, 2022

Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance 1 today during its annual investor conference.

December 8, 2022
·
12 min read
Business

KSQ Appoints Mahesh Karande to its Board of Directors

KSQ Therapeutics today announced the appointment of Mahesh Karande, President and CEO of Omega Therapeutics, to the company’s board of directors.

December 8, 2022
·
2 min read
Drug Development

Horizon Therapeutics plc Announces First Subject Dosed in Phase 1 Trial Evaluating HZN-457 for the Treatment of Gout

Horizon Therapeutics plc (Nasdaq: HZNP) today announced the first subject has been dosed in a Phase 1 randomized, placebo-controlled trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of its development-stage medicine HZN-457, previously known as ARO-XDH. HZN-457.

December 8, 2022
·
4 min read
Biotech Bay

Improvements in Signs and Symptoms of Dry Eye Disease From a Single TearCare® Treatment Sustained Through 12 Months

Sight Sciences, Inc. is pleased to report independent data addressing a frequent question from eyecare practitioners and patients regarding the treatment of meibomian gland disease using the TearCare® System: How long does a single treatment last?

December 8, 2022
·
10 min read